Document is current

Any future updates will be listed below

Correction: BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity

Crossref DOI link: https://doi.org/10.1038/s41388-025-03278-3

Published Online: 2025-01-22

Published Print: 2025-03-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark